Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

By Cynthia A. Binanay, R. Califf, V. Hasselblad, Christopher M. O'Connor, M. Shah, G. Sopko, L. Stevenson, Gary S. Francis, C. Leier, Leslie W. Miller. Journal of the American Medical Association (JAMA), 2005

836 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8d9a051bb9b5cb40e9cf25fa6275992dde180331

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Bozkurt
2. Kosuke Imai
3. M. Hoeper
4. Ben B. Hansen
5. M. Jessup
6. H. Ghofrani
7. M. Flemmer
8. R. Barst

Citations in the corpus

• Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. (2006, background): “It is this latter setting in which controversy persists with respect to the usefulness and safety of pulmonary artery catheters (29,37,38).”
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “pensated HF and congestion with symptomatic response to diuretics and vasodilators (127).”
• The sensitivity of linear regression coefficients' confidence limits to the omission of a confounder (2009, result): “…the results of subsequent randomized trials have been largely consistent with this picture [Rhodes et al. (2002); Sandhan et al. (2003); Shah and Stevenson (2004); Richard et al. (2003); Harvey et al. (2005)], the procedure remains a staple of critical care, and the surrounding debate continues.”
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “pensated HF and congestion with symptomatic response to diuretics and vasodilators (305).”
• The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (2014, background): “In addition, pulmonary artery catheters are not commonly placed duringhospitalization (51).”
• Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010, unknown): “capillary wedge pressure (PCWP) and reduced 6 min walk to be the strongest independent predictors in post-discharge mortality after hospitalization for worsened HF among all clinical, haemodynamic, and laboratory variables studied.(35) Several other studies have also shown that patients with haemody”
• Narrative Review (2012, background): “In-hospital adverse events were more common among patients in the PAC group; however, there were no significant differences in the 30-day mortality or clinical outcomes or adverse events at 6 months between the 2 groups of patients.(45) This study, in keeping with the critical care literature sugges”
• SCAI clinical expert consensus statement on the classification of cardiogenic shock (2019, background): “The prospective, randomized ESCAPE trial in patients with decompensated HF showed no benefit, and was stopped early due to safety concerns (infection, ICD firing).(40) However, these patients did not have acute coronary syndromes or CS and all patients were enrolled with clinical equipoise.”
• Cardiorenal interactions: insights from the ESCAPE trial. (2008, unknown): “The complete baseline haracteristics of the study population have been published reviously (7).”